Further studies in an olfactory bulbectomy (OBX) depression model revealed that GAL (1–15) enhanced FLX’s antidepressant-like effects in despair and anhedonia tests through 5-HT1AR modulation at the plasma membrane and transcriptional levels (Flores-Burgess et al., 2022). The gene discussed is GAL; the disease is major depressive disorder.